(AI) Artificial Intelligence in Drug Discovery Market Size Will Reach USD 5,558.0 Million by 2029, at 33.9% CAGR Growth: Polaris Market Research

According to the research report, the global artificial intelligence in drug discovery market was valued at USD 626.6 Million in 2021 and is expected to reach USD 5,558.0 Million by 2029, growing at a CAGR of 33.9% during the forecast period.

Artificial Intelligence (AI) uses complex algorithms and machine learning to acquire significant information from huge datasets. For instance, AI uses RNA sequencing data to recognize genes whose expression correlates with a given cellular condition. It employs the most recent advancements in biology to create cutting-edge medicine discovery algorithms. The increase in computer processing power, the development of advanced algorithms, and the availability of large datasets are the main drivers that led to the developments in machine learning.

Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/ai-in-drug-discovery-market/request-for-sample

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

Top Market Players Are:

Major participants such as GNS Healthcare, DeepMind, BIOAGE, Atomwise, Euretos, Benevolent AI, OWKIN, Inc., Berg Health, BioSymetrics, Insitro, Cloud Pharmaceuticals, Cyclica, Deep Genomics, Envisagenics, Exscientia, IBM Corporation, Insilico Medicine, NuMedii, Numerate, NVIDIA Corporation, Aria Pharmaceuticals, Inc., Verge Genomics, XtalPi Inc. are some of the key players operating in the global market. The companies in the industry are engaged in collaborations and expansions with several market platform providers to develop medical treatment.

Directly Purchase a copy of the report with TOC @ https://www.polarismarketresearch.com/checkouts/8171

Based on application, the global artificial intelligence (AI) in the drug discovery market is clustered into drug optimization & repurposing, preclinical testing, and others. The optimization & repurposing segment accounted for the largest revenue share in the industry as it is economical and demands only Electronic Medical Records (EMR) for medicine repurposing.

Based on therapeutic areas, the global market is classified into oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious diseases, and others. The oncology segment accounted for the largest revenue share in 2020 as it deals with the diagnosis and prevention of cancer.

Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/ai-in-drug-discovery-market/inquire-before-buying

(Inquire a report quote OR available discount offers to the sales team before purchase.)

There are some pharmaceutical companies that are focusing on integrating artificial intelligence with medicine discovery and development. For instance, Pfizer associated with IBM Watson Health, an AI platform, to augment their search for immuno-oncology treatments. Sanofi partnered with Exscientia to discover metabolic-disease therapies.

Browse detail report with in-depth TOC @ https://www.polarismarketresearch.com/industry-analysis/ai-in-drug-discovery-market

Polaris Market Research has segmented the artificial intelligence in drug discovery market report on the basis of application, therapeutic area, offering, technology, and region:

Artificial Intelligence in Drug Discovery, Application Outlook (Revenue - USD Million, 2017 - 2029)

Drug Optimization & Repurposing
Preclinical Testing
Others

Artificial Intelligence in Drug Discovery, Therapeutic Area Outlook (Revenue - USD Million, 2017 - 2029)

Oncology
Neurodegenerative Diseases
Cardiovascular Disease
Metabolic Diseases
Infectious Disease
Others

Artificial Intelligence in Drug Discovery, Offering Outlook (Revenue - USD Million, 2017 - 2029)

Software
Services

Artificial Intelligence in Drug Discovery, Technology Outlook (Revenue - USD Million, 2017 - 2029)

Machine Learning
Deep Learning
Supervised Learning
Reinforcement Learning
Unsupervised Learning
Other Machine Learning Technologies
Other Technologies

Contact Us:
Polaris Market Research
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Ph: +1-929 297-9727

About Us:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

This release was published on openPR.